04/19/2024 6:06 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024 7:43 AM | ProQR Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/13/2024 6:10 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024 6:46 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 5:08 AM | ProQR Therapeutics (Subject) VAN HERK INVESTMENTS B.V. (Filed by)
| Form SC 13G/A | |
02/09/2024 5:37 AM | ProQR Therapeutics (Subject) VAN HERK INVESTMENTS B.V. (Filed by)
| Form SC 13G/A | |
01/19/2024 6:08 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 6:08 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023 6:37 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023 6:37 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023 9:00 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2023 6:06 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023 4:20 PM | ProQR Therapeutics (Subject) VAN HERK INVESTMENTS B.V. (Filed by)
| Form SC 13G | |
08/03/2023 6:15 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023 6:15 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023 6:15 AM | ProQR Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2023 11:15 PM | ProQR Therapeutics (Filer)
| Form EFFECT | |
04/24/2023 3:30 PM | ProQR Therapeutics (Filer)
| Form 424B5 | |